↓ Skip to main content

Cochrane Database of Systematic Reviews

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
29 tweeters
facebook
2 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
244 Mendeley
Title
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
Published in
Cochrane database of systematic reviews, November 2018
DOI 10.1002/14651858.cd008170.pub3
Pubmed ID
Authors

Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 244 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 244 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 14%
Student > Master 25 10%
Researcher 23 9%
Student > Ph. D. Student 19 8%
Student > Postgraduate 18 7%
Other 46 19%
Unknown 78 32%
Readers by discipline Count As %
Medicine and Dentistry 78 32%
Nursing and Health Professions 21 9%
Pharmacology, Toxicology and Pharmaceutical Science 11 5%
Social Sciences 9 4%
Agricultural and Biological Sciences 6 2%
Other 33 14%
Unknown 86 35%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#1,358,873
of 21,753,060 outputs
Outputs from Cochrane database of systematic reviews
#3,196
of 12,100 outputs
Outputs of similar age
#35,591
of 336,909 outputs
Outputs of similar age from Cochrane database of systematic reviews
#31
of 60 outputs
Altmetric has tracked 21,753,060 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,100 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,909 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.